Text Size

The Prevalence of Metabolic Syndrome and Its Associated Factors in an Urban City

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2006 by China Medical University Hospital.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
National Science Council, Taiwan
Information provided by:
China Medical University Hospital
ClinicalTrials.gov Identifier:
NCT00308672
First received: March 29, 2006
Last updated: NA
Last verified: March 2006
History: No changes posted
  Purpose

The secondary objective is to evaluate the agreement between these criteria and the prevalence of concordant and discordant according to different criteria.


Condition
Prediabetes

Study Type: Observational
Study Design: Allocation: Random Sample
Primary Purpose: Screening
Time Perspective: Cross-Sectional
Time Perspective: Retrospective/Prospective
Official Title: The Study for the Prevalence of Metabolic Syndrome and Its Associated Factors in an Urban City- Comparison of Agreement for Prevalence of Metabolic Syndrome Among the WHO, NCEP ATP III and Taiwan Definitions

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by China Medical University Hospital:

Estimated Enrollment: 3000
Study Start Date: August 2005
Estimated Study Completion Date: July 2006
Detailed Description:

Up to now, there has been to uniform case definition for the metabolic syndrome. The World Health Organization and the Third Report of the National Cholesterol Education Program's Adult Treatment Panel (ATP III), and Bureau of Health Promotion, Taiwan proposed different criteria for the metabolic syndrome. Therefore, the secondary objective is to evaluate the agreement between these criteria and the prevalence of concordant and discordant according to different criteria. Three thousand persons will be randomly selected from resident of Taichung City. All the participants will fulfill a structured questionnaire. Blood pressure, anthropometric variables are measured. Biochemical markers are analyzed by a biochemical autoanalyzer. Kappa will be used to estimate the agreement between different criteria.

  Eligibility

Ages Eligible for Study:   40 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

Residents aged 40 and over of Taichung City, Taiwan in October, 2004.

Exclusion Criteria:

-

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00308672

Contacts
Contact: Li C Ing, MS. 886-4-22052121 ext 4263 a6446@www.cmuh.org.tw

Locations
Taiwan
China Medical University Hospital Recruiting
Taichung city, Taiwan, 404
Contact: Li C Ing, MS     886-4-22052121 ext 4263     a6446@www.cmuh.org.tw    
Sponsors and Collaborators
China Medical University Hospital
National Science Council, Taiwan
Investigators
Principal Investigator: Lin C Chieh, Professor School of Medicine, China Medical Universtiy
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00308672     History of Changes
Other Study ID Numbers: NSC94-2314-B-039-024
Study First Received: March 29, 2006
Last Updated: March 29, 2006
Health Authority: Taiwan: Department of Health

Additional relevant MeSH terms:
Glucose Intolerance
Prediabetic State
Metabolic Syndrome X
Hyperglycemia
Glucose Metabolism Disorders
 Metabolic Diseases
Diabetes Mellitus
Endocrine System Diseases
Insulin Resistance
Hyperinsulinism

ClinicalTrials.gov processed this record on May 16, 2013